Thu, Jul 10, 2014, 8:04 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Facebook, Inc. (FB) Message Board

burnaka 1962 posts  |  Last Activity: Jul 3, 2014 11:04 AM Member since: May 19, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Gorgeous chart on ARRY,

    by cl124cl Jul 2, 2014 10:06 AM
    burnaka@sbcglobal.net burnaka Jul 3, 2014 11:04 AM Flag

    Maybe, I just noticed irwd the other day, funds own 118%, short interest down 5 million, sales of their one drug growing q/q through various partners, mainly Forest labs.

    LINZESS net product sales, as reported by Forest Laboratories, Inc., were $51.0 million in the fourth quarter of 2013, an increase of approximately 48% quarter over quarter, and $118.8 million for the year ended December 31, 2013.
    • LINZESS net product sales, as reported by Forest Laboratories, Inc., were $60.8 million in the first quarter of 2014, an increase of approximately 19% quarter over quarter.

    So at 60m Q1 = 240 annual, a double from 2013 sales of 118.

    Their pipeline appears smallish and much around this one drug, but looks like they have a global plan for the drug with partners other than forest, maybe double the 240, to 480M if global plan works. It is worth following, but I am not in a position to jump in at this point.

  • Reply to

    Gorgeous chart on ARRY,

    by cl124cl Jul 2, 2014 10:06 AM
    burnaka@sbcglobal.net burnaka Jul 3, 2014 9:05 AM Flag

    I can't speak to all the technical, but you want a nice chart look at ironwood pharma, irwd. Not sure if this heads to all time highs, or is ready to top, but the chart is awesome.

  • Reply to

    WOW 1,400,000 shares available for the shorts...

    by opkolong Jul 2, 2014 10:33 AM
    burnaka@sbcglobal.net burnaka Jul 2, 2014 3:31 PM Flag

    Google interactive brokers

  • burnaka@sbcglobal.net by burnaka Jul 2, 2014 1:34 PM Flag

    still many in the urology ( 4k score ) for regional managers. 4k roll out will take time, still 15 regions open.

  • Reply to

    WOW 1,400,000 shares available for the shorts...

    by opkolong Jul 2, 2014 10:33 AM
    burnaka@sbcglobal.net burnaka Jul 2, 2014 11:33 AM Flag

    I just noticed arry went from 1.6m, to over 4m, both arry and opk are Russel members, wonder if the Friday rebalance cleared today and some how that influenced these numbers?

  • Reply to

    WOW 1,400,000 shares available for the shorts...

    by opkolong Jul 2, 2014 10:33 AM
    burnaka@sbcglobal.net burnaka Jul 2, 2014 11:18 AM Flag

    A fund could easily say, ok, mine are now available for x interest, plus not sure how it works for trades to clear, for me it is 3 days, so you might be seeing the availability go up from trades that occurred a couple days ago that cleared today. Just a thought.

    Available shares have to be made available by a person or institution willing to lend. The number moves around, but this is way more than usual. This might be part of the shares exchanged from the note offering hitting a fund too, no way to tell where they magically appeared from, just KNOW they are not Dr. Frost's, lol.

  • Reply to

    WOW 1,400,000 shares available for the shorts...

    by opkolong Jul 2, 2014 10:33 AM
    burnaka@sbcglobal.net burnaka Jul 2, 2014 10:50 AM Flag

    When a short covers 1,400,000 those shares are back in the available to short pool. When no one is covering, the number of available shares to short shrinks. If every available share to short is shorted there is zero available, if someone covers 100 shares, then that 100 becomes available again. The other factor is shares entering margin accounts, and fund buys, most funds lend out. So if a fund upped their position the availability moves up.

  • Reply to

    Big pre-market trade

    by cl124cl Jul 1, 2014 9:13 AM
    burnaka@sbcglobal.net burnaka Jul 1, 2014 2:29 PM Flag

    Not until you mentioned it. That fund that upped it's stake in arry, I looked over a few of their holdings, it is a bio only fund. A new buy was ccxi, up as arry past two days, range 4.57-14.75, currently 5.97, it is sort of interesting too.

  • Reply to

    Big pre-market trade

    by cl124cl Jul 1, 2014 9:13 AM
    burnaka@sbcglobal.net burnaka Jul 1, 2014 12:29 PM Flag

    The market is up big, the last time arry saw 4.75 was April 1, Can get to 5.00 if flippers and shorts give it a rest. Since April 1, only 2 million more shorts added, ie., are under water, some others need lock in profits to give it that push lol. 16.4 m short, 14m profitable. Time to take some off the table.

  • Reply to

    What if A giant Meteor strikes Earth today?

    by miamianne67 Jul 1, 2014 10:32 AM
    burnaka@sbcglobal.net burnaka Jul 1, 2014 11:15 AM Flag

    Short convention at the trailer park next to the big tree, be there, aloha.

  • Reply to

    What if Frost is wrong about this company

    by diejour_44 Jul 1, 2014 8:55 AM
    burnaka@sbcglobal.net burnaka Jul 1, 2014 11:08 AM Flag

    diejour, your comment makes no sense. " What if he is wrong " This is not a test where you get a paper back with red marks on the wrong answers. It is a company that is evolving with new parts being added and being developed constantly. Some will likely fail, be sold off ( as optics was ), some will be merged with bigger pharma in time. Frost will keep adding and subtracting as he always has done until he has the right mix of successful divisions, it will take time. He has the knowledge, connections and the MONEY to make his PROJECT work. This is a guy who handed OPKO for free 900K shares of stock from his personal holdings. Might seem small but taking his cash and handing it over to his company shows commitment to the company and the BALANCE sheet. The drugs in the pipeline currently are the type few others are pursuing and many are long acting versions of established items, one needle a week, not 7 a week, um, Frost knows what he is doing, not sure betting against this guy has ever worked in the long run, in fact I know it hasn't, see Key, see Ivax, and others.

  • Reply to

    Big pre-market trade

    by cl124cl Jul 1, 2014 9:13 AM
    burnaka@sbcglobal.net burnaka Jul 1, 2014 10:10 AM Flag

    Arry is in about 20 etfs, and was added to the Russell some time ago. Google alletf to see the etf funds holding any stock.

  • Reply to

    New SEC filing

    by buyoutmoney175 Jun 28, 2014 10:40 AM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 10:48 PM Flag

    CL, You should do whatever you think is in your best financial interest. I trade neither, established my positions, so that is it for me. Opk is a stealth stock, their portfolio is considered mediocre, weak, etc., it will destroy estimates, Frost is in areas nobody is bothering with at all, competition is non existent for their ckd products.

    Arry, has a far wider net, broad portfolio, in crowded markets. Arry's drugs have bling, and arry might out perform opk in the next 18 months, I am leaning that way. By eoy 2016, early 2017 opk gets respect. By early 2017 I think opko is by far the better bet, but one home run here, or a buy out in a year ( likely ) arry wins the mile, opko the marathon.

    Keeping shares in each is a hedge.

  • Reply to

    New SEC filing

    by buyoutmoney175 Jun 28, 2014 10:40 AM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 8:31 PM Flag

    If you look at this funds holdings arry is now their 3rd largest holding, was 4th. They only own 28 positions so this is a BIG bet on their part.

  • Reply to

    Something has got to give!!!

    by lottawatta2013 Jun 30, 2014 3:48 PM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 7:05 PM Flag

    Rayaldy may be a catalyst, not sure the market fully gets the potential revenue of Rayaldy, thinking there are many doubters. They will be proven wrong, time will fix any misconception.

  • Reply to

    what a shame

    by checkmeouta Jun 30, 2014 2:04 PM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 2:55 PM Flag

    Hit 4.52 for the first time since April 4th during the bio sell off, a week ago hit 4.48 first time since April 10, so it is attempting to recover. The highest close since April 4th 4.45 about 8 days ago, needs get over and close above 4.45. 4.50 works, maybe by Wed. Hitting 4.52 bodes well, so the guy saying back to 5+ is on track.

  • Reply to

    Burnaka, O T

    by cl122cl Jun 29, 2014 1:45 PM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 1:34 PM Flag

    Yes at .30 downside is limited, I do expect financing, maybe a note, ala opko type, also RS split not off the table to uplist it to a different exchange, 1 for 20 only gets it to 6.00, unless it runs back over a buck. It has been in a slow fall for quite a while. Maybe when they start phase 1, it gets a pop. good luck with it.How about TRXC ? U own that one?

  • Reply to

    ARRY to make a run in July

    by waiting4_arry Jun 27, 2014 8:05 AM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 12:44 PM Flag

    PS, I do not do thumbs up or down, lol.

  • Reply to

    ARRY to make a run in July

    by waiting4_arry Jun 27, 2014 8:05 AM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 12:11 PM Flag

    Waiting4, I have no reason to print out your post, would never call you a liar. I would love to see this run, it has run in July in both 2012 and 2013, but in those years it also got an asco pop. Seems the catalysts that moved this in the past no longer are working, so figure it might take real news. Need see it get over 4.50 on volume before I believe it can continue, so far it has struggled at 4.48 and failed to break out. I am long and patient, but not adding.

  • Reply to

    Burnaka, O T

    by cl122cl Jun 29, 2014 1:45 PM
    burnaka@sbcglobal.net burnaka Jun 30, 2014 12:02 PM Flag

    Opinion? Not really, but at .30 it is worth a flyer. The technology is interesting for sure. Has Teva and Frost holding their hand so big brothers might help them along. Interesting that opko owns or has an interest in a Taiwan company that is ALSO targeting the common cold. Opko took an interest about two years ago and has to pay X a year to aid the research yet nothing is ever said about any progress. Cocp will need more cash in about 1 year, a reverse split is not off the table. Not one drug even in phase one, but planned, so it is a multi-year investment, 10-12, unless a buyer wants their patent library. The low volume and not too large share count could make this an easy double on any SA manipulative article. Though the technology will likely work it will take a lot of time and patience to see it through. Planned phase 1 studies, hep c first, influenza? then common cold, 2015, 2016, 2017 I think.

FB
64.8725-0.0975(-0.15%)Jul 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.